ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,528,864, issued on Jan. 20, was assigned to GlaxoSmithKline Intellectual Property Development Ltd. (Stevenage, Great Britain).
"Antigen binding proteins" was invented by Yan Y. Degenhardt (Collegeville, Pa.), Jun Guan (Collegeville, Pa.), Kenneth William Hance (Collegeville, Pa.) and Peter Joseph Morley (Stevenage, Great Britain).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to compositions for treating CD96 mediated diseases, and related methods."
The patent was filed on Sept. 2, 2022, under Application No. 17/902,305.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/ne...